why choose us

First received: September 22, 2023

Clinical Trial: DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment

Study Status: Completed

Recruit Status: RECRUITING

Condition: Ductal Carcinoma in Situ

Study Type: INTERVENTIONAL


Official Title: DCIS: RECAST Trial -Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment: a Breast Cancer Prevention Pilot Study

Brief Summary: The goal of this trial is to see if active surveillance monitoring and hormonal therapy in patients diagnosed with ductal cell carcinoma in situ (DCIS), an early stage of breast cancer, can be an effective management of the disease.Participants will be asked to receive standard of care hormonal therapy or an investigational treatment.Participants will be asked to return for evaluation with MRI at three months and six months.Depending on the evaluation participants will have the option to continue on the…

Read more